These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9620529)

  • 1. Human malignant hyperthermia associated with desflurane anesthesia.
    Allen GC; Brubaker CL
    Anesth Analg; 1998 Jun; 86(6):1328-31. PubMed ID: 9620529
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant hyperthermia during desflurane-succinylcholine anesthesia for orthopedic surgery.
    Garrido S; Fraga M; Martín MJ; Belda J
    Anesthesiology; 1999 Apr; 90(4):1208-9. PubMed ID: 10201695
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of suspected malignant hyperthermia during desflurane administration.
    Michalek-Sauberer A; Fricker R; Gradwohl I; Gilly H
    Anesth Analg; 1997 Aug; 85(2):461-2. PubMed ID: 9249131
    [No Abstract]   [Full Text] [Related]  

  • 4. An unusual case of malignant hyperthermia during desflurane anesthesia in an African-American patient.
    Lane JE; Brooks AG; Logan MS; Newman WH; Castresana MR
    Anesth Analg; 2000 Oct; 91(4):1032-4, table of contents. PubMed ID: 11004072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anesthetic drugs and onset of malignant hyperthermia.
    Visoiu M; Young MC; Wieland K; Brandom BW
    Anesth Analg; 2014 Feb; 118(2):388-396. PubMed ID: 24445637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed onset of malignant hyperthermia in desflurane anesthesia.
    Hoenemann CW; Halene-Holtgraeve TB; Booke M; Hinder F; Daudel F; Reich A; Van Aken H
    Anesth Analg; 2003 Jan; 96(1):165-7, table of contents. PubMed ID: 12505945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mild variant of malignant hyperthermia following succinylcholine and halogenated agent exposure].
    Fernández-García V; Bermejo MA; Vázquez C; Pereda MJ; Altarriba JM; Alvarez E
    Rev Esp Anestesiol Reanim; 1995 Nov; 42(9):401-2. PubMed ID: 8584782
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignant hyperthermia: description and case report.
    Gohil P; Forman WM
    J Foot Surg; 1982; 21(1):7-11. PubMed ID: 7069146
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant hyperthermia in a liver transplant patient: a case report.
    Fernandes CR; Azevedo DM; Gomes JM; Gonçalves BP; Coelho GR; Vasconcelos JB; Garcia JH
    Transplant Proc; 2007 Dec; 39(10):3530-2. PubMed ID: 18089429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant hyperthermia].
    Bouhajja B; Haddad F; Ben Ammar MS
    Tunis Med; 2002 Jul; 80(7):395-401. PubMed ID: 12611349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognizing and treating malignant hyperthermia.
    Corvetto MA; Taekman JM
    Simul Healthc; 2010 Jun; 5(3):169-72. PubMed ID: 20651479
    [No Abstract]   [Full Text] [Related]  

  • 12. [Atypical malignant hyperthermia. A higher incidence than expected].
    Herrero E; Casinello F; de Stefano J; Fernández-Guisasola J; Pérez-Gallardo A
    Rev Esp Anestesiol Reanim; 1996 Jan; 43(1):42-3. PubMed ID: 8851836
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of malignant hyperthermia without hyperthermia].
    Muiños PA; Ortells MA; Sánchez G; Carrasco MS
    Rev Esp Anestesiol Reanim; 1995 Dec; 42(10):436. PubMed ID: 8789530
    [No Abstract]   [Full Text] [Related]  

  • 14. The severity of sevoflurane-induced malignant hyperthermia.
    Migita T; Mukaida K; Kobayashi M; Hamada H; Kawamoto M
    Acta Anaesthesiol Scand; 2012 Mar; 56(3):351-6. PubMed ID: 22092278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No response to trigger agents in a malignant hyperthermia-susceptible patient.
    Claxton BA; Cross MH; Hopkins PM
    Br J Anaesth; 2002 Jun; 88(6):870-3. PubMed ID: 12173209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suxamethonium, masseter spasm and later malignant hyperthermia.
    Ramirez JA; Cheetham ED; Laurence AS; Hopkins PM
    Anaesthesia; 1998 Nov; 53(11):1111-6. PubMed ID: 10023282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A suspected malignant hyperthermia episode during desflurane anesthesia.
    Lowes R; Mayhew JF
    Anesth Analg; 1998 Feb; 86(2):449-50. PubMed ID: 9459273
    [No Abstract]   [Full Text] [Related]  

  • 18. Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation.
    Hogan KJ; Vladutiu GD
    Anesth Analg; 2009 Oct; 109(4):1070-2. PubMed ID: 19762733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desflurane, malignant hyperthermia, and release of compartment syndrome.
    Uskova AA; Matusic BP; Brandom BW
    Anesth Analg; 2005 May; 100(5):1357-1360. PubMed ID: 15845684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of suspected malignant hyperthermia during desflurane administration.
    Celebioglu B
    Anesth Analg; 1998 Apr; 86(4):916. PubMed ID: 9539628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.